Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FTC
Fierce Biotech
FTC tells Novo that Metsera offer may violate US merger law
The proposed purchase of Metsera by Novo "may violate the procedural provisions" of the Hart-Scott-Rodino Act, an FTC official wrote.
Eric Sagonowsky
Nov 5, 2025 4:26pm
Maze, Vertex marketing spat escalates to federal regulators
Aug 28, 2025 10:49am
In less than 3 months, AbbVie closes $10.1B buyout of ImmunoGen
Feb 12, 2024 10:55am
M&A is on the rise. Analysts see more of the same in 2024
Dec 22, 2023 8:46am
Pfizer says $43B buyout of Seagen will be complete this week
Dec 12, 2023 10:56am
FTC takes aim at 'sham' biopharma patents
Sep 14, 2023 3:55pm
